These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36991484)

  • 1. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.
    Alam MS; Sultana A; Wang G; Haque Mollah MN
    Front Mol Biosci; 2022; 9():1049741. PubMed ID: 36567949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer.
    Hossen MB; Islam MA; Reza MS; Kibria MK; Horaira MA; Tuly KF; Faruqe MO; Kabir F; Mollah MNH
    Comput Biol Med; 2023 Jan; 152():106411. PubMed ID: 36502691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer.
    Alam MS; Sultana A; Sun H; Wu J; Guo F; Li Q; Ren H; Hao Z; Zhang Y; Wang G
    Front Pharmacol; 2022; 13():942126. PubMed ID: 36204232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer.
    Islam MA; Hossen MB; Horaira MA; Hossen MA; Kibria MK; Reza MS; Tuly KF; Faruqe MO; Kabir F; Mahumud RA; Mollah MNH
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications.
    Ahmmed R; Hossen MB; Ajadee A; Mahmud S; Ali MA; Mollah MMH; Reza MS; Islam MA; Mollah MNH
    Sci Rep; 2024 Aug; 14(1):19133. PubMed ID: 39160196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.
    Ajadee A; Mahmud S; Hossain MB; Ahmmed R; Ali MA; Reza MS; Sarker SK; Mollah MNH
    PLoS One; 2024; 19(9):e0310843. PubMed ID: 39348357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer.
    Huang JC; Li MC; Huang IC; Hu JM; Lin WZ; Chang YT
    Hum Gene Ther; 2024 Oct; 35(19-20):855-867. PubMed ID: 38767504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches.
    Sultana A; Alam MS; Liu X; Sharma R; Singla RK; Gundamaraju R; Shen B
    Transl Oncol; 2023 Jan; 27():101571. PubMed ID: 36401966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
    Ding B; Yao M; Fan W; Lou W
    Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
    Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
    PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer.
    Alam MS; Rahaman MM; Sultana A; Wang G; Mollah MNH
    Comput Biol Med; 2022 Jun; 145():105508. PubMed ID: 35447458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer.
    Chacon-Millan P; Lama S; Del Gaudio N; Gravina AG; Federico A; Pellegrino R; Luce A; Altucci L; Facchiano A; Caraglia M; Stiuso P
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches.
    Ahmed FF; Das AD; Sumi MJ; Islam MZ; Rahman MS; Rashid MH; Alyami SA; Alotaibi N; Azad AKM; Moni MA
    Sci Rep; 2023 Nov; 13(1):19072. PubMed ID: 37925496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hub Genes for Colorectal Cancer with Liver Metastasis Using miRNA-mRNA Network.
    Zhang SM; Shen C; Li J; Wang XD; Zhai SQ; Shi LL; Lu DL; Jiang XH; Qiu J
    Dis Markers; 2023; 2023():2295788. PubMed ID: 36798788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.